Portfolio company
Oxailis
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops AI software for 3D ultrasound analysis to quantify tissue perfusion for healthcare providers in obstetrics, oncology and nephrology.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Biotics.ai
The company develops artificial intelligence software for medical imaging to detect abnormalities in fetal and maternal ultrasound screenings for obstetricians and healthcare providers.
Oncoustics
This company develops AI-powered software that analyses raw ultrasound signals for non-invasive liver disease diagnostics and tissue characterisation for clinics and pharmaceutical partners.
Oxipit
This company develops artificial intelligence software for medical imaging to automate radiology reporting and diagnostic quality control for healthcare providers.
Diagnoly
This company develops artificial intelligence software for prenatal ultrasound imaging to help healthcare professionals detect fetal abnormalities.
BrightHeart
This company develops AI software for clinicians to improve the detection of congenital heart defects during routine prenatal ultrasound exams.
Medo
This company develops artificial intelligence software for ultrasound imaging to assist healthcare professionals in diagnosing medical conditions.
Angiogenesis Analytics
This company develops AI-powered software that analyses ultrasound images to help urologists detect and locate prostate cancer tumours.
Microvessel cancer diagnostic
This company develops high-definition ultrasound imaging software to help clinicians non-invasively differentiate between malignant and benign tumours by visualising small blood vessels.
